Pharmacotherapy of atrial fibrillation

Jan Nemec; Win Kuang Shen

doi:10.1517/14656566.1.1.81

Pharmacotherapy of atrial fibrillation

Jan Nemec, Win Kuang Shen

Cardiovascular Diseases

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Atrial fibrillation (AF) remains a widespread health problem and the drugs available for its treatment suffer from several drawbacks, including potentially lethal proarrhythmia, serious non-cardiac toxicity and limited efficacy. The evidence for efficacy of currently available anti-arrhythmic agents for sinus rhythm restoration and maintenance is reviewed, with emphasis on randomised trials when available. The current approach to thromboembolism prophylaxis in AF is summarised. 1999

Original language	English (US)
Pages (from-to)	81-96
Number of pages	16
Journal	Expert Opinion on Pharmacotherapy
Volume	1
Issue number	1
DOIs	https://doi.org/10.1517/14656566.1.1.81
State	Published - Jan 1 1999

Keywords

Anti-arrhythmic drugs
Anticoagiilation
Atrial fibrillation
Thromboembolism
Treatment

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1517/14656566.1.1.81

Cite this

@article{363e29ba27bf4fa9a20e1da6467f5522,

title = "Pharmacotherapy of atrial fibrillation",

abstract = "Atrial fibrillation (AF) remains a widespread health problem and the drugs available for its treatment suffer from several drawbacks, including potentially lethal proarrhythmia, serious non-cardiac toxicity and limited efficacy. The evidence for efficacy of currently available anti-arrhythmic agents for sinus rhythm restoration and maintenance is reviewed, with emphasis on randomised trials when available. The current approach to thromboembolism prophylaxis in AF is summarised. 1999",

keywords = "Anti-arrhythmic drugs, Anticoagiilation, Atrial fibrillation, Thromboembolism, Treatment",

author = "Jan Nemec and Shen, {Win Kuang}",

year = "1999",

month = jan,

day = "1",

doi = "10.1517/14656566.1.1.81",

language = "English (US)",

volume = "1",

pages = "81--96",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Pharmacotherapy of atrial fibrillation

AU - Nemec, Jan

AU - Shen, Win Kuang

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Atrial fibrillation (AF) remains a widespread health problem and the drugs available for its treatment suffer from several drawbacks, including potentially lethal proarrhythmia, serious non-cardiac toxicity and limited efficacy. The evidence for efficacy of currently available anti-arrhythmic agents for sinus rhythm restoration and maintenance is reviewed, with emphasis on randomised trials when available. The current approach to thromboembolism prophylaxis in AF is summarised. 1999

AB - Atrial fibrillation (AF) remains a widespread health problem and the drugs available for its treatment suffer from several drawbacks, including potentially lethal proarrhythmia, serious non-cardiac toxicity and limited efficacy. The evidence for efficacy of currently available anti-arrhythmic agents for sinus rhythm restoration and maintenance is reviewed, with emphasis on randomised trials when available. The current approach to thromboembolism prophylaxis in AF is summarised. 1999

KW - Anti-arrhythmic drugs

KW - Anticoagiilation

KW - Atrial fibrillation

KW - Thromboembolism

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0033224588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033224588&partnerID=8YFLogxK

U2 - 10.1517/14656566.1.1.81

DO - 10.1517/14656566.1.1.81

M3 - Article

C2 - 11249567

AN - SCOPUS:0033224588

SN - 1465-6566

VL - 1

SP - 81

EP - 96

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

IS - 1

ER -

Pharmacotherapy of atrial fibrillation

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this